Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Three-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome

ClinicalTrials.gov ID: NCT05349214

Public ClinicalTrials.gov record NCT05349214. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 9:50 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo Controlled, 3-arm Multicenter Phase 3 Study to Assess the Efficacy and Safety of Ianalumab in Patients With Active Sjogren's Syndrome (NEPTUNUS-2)

Study identification

NCT ID
NCT05349214
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
506 participants

Conditions and interventions

Interventions

  • VAY736 Biological
  • Placebo Other

Biological · Other

Eligibility (public fields only)

Age range
18 Years to 100 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 3, 2022
Primary completion
May 12, 2025
Completion
Apr 14, 2027
Last update posted
Jun 16, 2026

2022 – 2027

United States locations

U.S. sites
23
U.S. states
13
U.S. cities
22
Facility City State ZIP Site status
Providence Medical Foundation Fullerton California 92835
Advanced Medical Research La Palma California 90623
Bay Area Arthritis And Osteoporosis Brandon Florida 33511
GNP Research Cooper City Florida 33024
Sarasota Arthritis Res Ctr Sarasota Florida 34239
Augusta University Georgia Augusta Georgia 30912
North Georgia Rheumatology Group Lawrenceville Georgia 30046
Clin Invest Specialists Inc Orland Park Illinois 60467
Clinic of Robert Hozman Skokie Illinois 60176
Clinical Investigation Specialists, Inc. Wauconda Illinois 60084
University of Kansas Hospital Kansas City Kansas 66160
Tufts School of Dental Medicine Boston Massachusetts 02111
Arthritis Osteoporosis Assoc of NM Las Cruces New Mexico 88011
St Lawrence Health System Potsdam New York 13676
Arthritis and Osteoporosis Charlotte North Carolina 28202
On Site Clinical Solutions Llc Charlotte North Carolina 28202
RAO Research LLC Oklahoma City Oklahoma 73116
West Tennessee Research Institute Jackson Tennessee 38305
Ramesh C Gupta MD Memphis TN Memphis Tennessee 38119
Prolato Clinical Research Center Houston Texas 77054
First Outpatient Research Unit San Antonio Texas 78229
Advanced Rheumatology of Houston Spring Texas 77382
Arthritis Northwest PLLC Spokane Washington 99216

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 123 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05349214, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 16, 2026 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05349214 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →